PCI Biotech presenting at Bio€quity Europe
Oslo, Norway, May 23, 2017 – PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, is presenting the Company at Bio€quity Europe, an investor and partnering event. Dr. Per Walday, CEO, will present an overview of PCI Biotech’s technology and the multiple business Development and commercial opportunities available based […]
PCI Biotech and RXi Pharmaceuticals Extend Research Collaboration to the Field of Immuno-oncology
Oslo (Norway), 22 May 2017 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, and RXi Pharmaceuticals (NASDAQ: RXII) a biotechnology company focused on developing novel RNAi therapeutics for significant un-met needs, today announced that they are extending their preclinical research collaboration initiated April 7, 2015. This extension is supported by a new preclinical […]
PCI Biotech to present at Bio€quity Europe
Oslo, Norway, May 18, 2017 – PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present the Company at Bio€quity Europe, an investor and partnering event. The event is taking place at Paris Marriot Rive Gauche Conference Center, France, 22-23 May 2017. Dr. Per Walday, […]